We are live on ! Find out more
PACB icon

Pacific Biosciences
PACB

151 hedge funds and large institutions have $375M invested in Pacific Biosciences in 2020 Q2 according to their latest regulatory filings, with 34 funds opening new positions, 47 increasing their positions, 38 reducing their positions, and 15 closing their positions.

New
Increased
Maintained
Reduced
Closed

127% more first-time investments, than exits

New positions opened: 34 | Existing positions closed: 15

116% more call options, than puts

Call options by funds: $1.18M | Put options by funds: $545K

24% more repeat investments, than reductions

Existing positions increased: 47 | Existing positions reduced: 38

14% more funds holding

Funds holding: 132 → 151 (+19)

4% more capital invested

Capital invested by funds: $361M → $375M (+$14.2M)

6.38% less ownership

Funds ownership: 76.89% → 70.5% (-6.4%)

50% less funds holding in top 10

Funds holding in top 10: 2 → 1 (-1)

Holders
151
Holders Change
+19
Holders Change %
+14.39%
% of All Funds
3.1%
Holding in Top 10
1
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-50%
% of All Funds
0.02%
New
34
Increased
47
Reduced
38
Closed
15
Calls
$1.18M
Puts
$545K
Net Calls
+$631K
Net Calls Change
+$791K

Top Buyers

1
AIM
ARK Investment Management
Florida
+$13.7M
2
Morgan Stanley
Morgan Stanley
New York
+$3.94M
3
BG
Bellevue Group
Switzerland
+$3.35M
4
State Street
State Street
Massachusetts
+$2.25M
5
Ameriprise
Ameriprise
Minnesota
+$2.14M

Top Sellers

1
WMSA
Weiss Multi-Strategy Advisers
New York
-$13.7M
2
ACH
ArrowMark Colorado Holdings
Colorado
-$8.62M
3
CCM
Camber Capital Management
Massachusetts
-$7.65M
4
Goldman Sachs
Goldman Sachs
New York
-$5.78M
5
KLCMU
Kite Lake Capital Management (UK)
United Kingdom
-$5.08M
Name Holding Trade Value Shares
Change 		Change in
Stake
Goldman Sachs
26
Goldman Sachs
New York
$3.17M -$5.78M -1,696,594 -65%
PIM
27
Platinum Investment Management
Australia
$2.96M +$1.21M +356,830 +71%
GCIA
28
Gabelli & Co Investment Advisers
New York
$2.53M -$739K -217,057 -23%
State of Wisconsin Investment Board
29
State of Wisconsin Investment Board
Wisconsin
$2.26M -$92.6K -27,200 -4%
SCM
30
Segantii Capital Management
Hong Kong
$2.19M – – –
N
31
Nuveen
North Carolina
$1.94M -$41.3K -12,128 -2%
BLAM
32
Bourne Lent Asset Management
New York
$1.92M – – –
HA
33
Heartland Advisors
Wisconsin
$1.73M +$681K +200,000 +67%
TCM
34
Tekla Capital Management
Massachusetts
$1.71M – – –
D.E. Shaw & Co
35
D.E. Shaw & Co
New York
$1.5M +$754K +221,594 +104%
MOACM
36
Mutual of America Capital Management
New York
$1.48M +$240K +70,502 +20%
LOAMU
37
Lombard Odier Asset Management (USA)
New York
$1.41M – – –
GI
38
GAMCO Investors
Connecticut
$1.26M -$27.2K -8,000 -2%
California Public Employees Retirement System
39
California Public Employees Retirement System
California
$1.11M +$14.6K +4,300 +1%
Swiss National Bank
40
Swiss National Bank
Switzerland
$1.06M +$188K +55,200 +22%
HA
41
Havens Advisors
New York
$1.02M -$43.1K -12,664 -4%
Deutsche Bank
42
Deutsche Bank
Germany
$845K +$590K +173,225 +242%
Los Angeles Capital Management
43
Los Angeles Capital Management
California
$831K +$820K +240,859 New
WMSA
44
Weiss Multi-Strategy Advisers
New York
$772K -$13.7M -4,034,894 -95%
California State Teachers Retirement System (CalSTRS)
45
California State Teachers Retirement System (CalSTRS)
California
$742K – – –
RhumbLine Advisers
46
RhumbLine Advisers
Massachusetts
$730K +$58.3K +17,121 +9%
Mariner
47
Mariner
Kansas
$703K – – –
AllianceBernstein
48
AllianceBernstein
Tennessee
$677K – – –
Jacobs Levy Equity Management
49
Jacobs Levy Equity Management
New Jersey
$667K +$659K +193,469 New
Citadel Advisors
50
Citadel Advisors
Florida
$592K +$203K +59,755 +53%
1
2
3 4 5

PACB Hedge Fund Activity: Q2 2020 in Review

151 of the 4,877 institutional investors tracked by Wall St. Rank reported a position in Pacific Biosciences (PACB) for Q2 2020, worth a combined $375M — up 3.9% from $361M a quarter earlier.

Buyers outnumbered sellers: 34 funds opened new PACB positions and 15 closed out — a net gain of 19 holders — while 47 added to existing stakes and 38 trimmed.

The largest buyer was ARK Investment Management, adding an estimated $13.7M. The largest seller was Weiss Multi-Strategy Advisers, cutting an estimated $13.7M.

  • 151 institutional investors held Pacific Biosciences (PACB) as of Q2 2020, up from 132 in Q1 2020.
  • Funds reported $375M of Pacific Biosciences stock for Q2 2020, up 3.9% quarter-over-quarter.
  • 34 funds opened new Pacific Biosciences positions in Q2 2020 and 15 closed out, a net change of +19 holders.
  • The largest Pacific Biosciences buyer in Q2 2020 was ARK Investment Management, an estimated $13.7M added.
  • The largest Pacific Biosciences seller in Q2 2020 was Weiss Multi-Strategy Advisers, an estimated $13.7M sold.

Based on aggregated 13F filings for Q2 2020.